Articles avec comité de lecture de revues internationales

301 - 

Analysis of the 2015 American and European guidelines for the management of infective endocarditis Analyse des recommandations américaines et européennes de 2015 pour la prise en charge des endocardites infectieuses

Pierre Tattevin, Jean-Luc Mainardi

Analysis of the 2015 American and European guidelines for the management of infective endocarditis. Médecine et Maladies Infectieuses, 2016, 46 (8), 406-410.

DOI : https://doi.org/10.1016/j.medmal.2016.05.008

Pubmed : 27297743

 

302 - 

Therapeutic drug monitoring of ganciclovir in CMV infections: Should we reassess the therapeutic range?

C. Tron, C. Arnoult, C. Leven, P. Fillatre, C. Pronier, M. Revest, M. C. Verdier, E. Bellissant, F Lemaitre

Fundamental & Clinical Pharmacology, 2016, 30, 43.

 

303 - 

Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems

Camille Tron, Cyril Leven, Pierre Fillâtre, Nicolas Maillard, Nicolas Nesseler, P. Tattevin, Erwan Flécher, Eric Bellissant, Marie-Clémence Verdier, Florian Lemaitre

Clinical and Experimental Pharmacology and Physiology, 2016, 43 (2), pp.281-283.

DOI : https://doi.org/10.1111/1440-1681.12527

Pubmed : 26667301

 

304 - 

The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.

Sarah Tubiana, Xavier Duval, François Alla, Christine Selton-Suty, Pierre Tattevin, F. Delahaye, Lionel Piroth, Catherine Chirouze, Jean-Philippe Lavigne, Marie-Line Erpelding, Bruno Hoen, F. Vandenesch, Bernard Iung, Vincent Le Moing

The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. Journal of Infection, 2016, 72 (5), 544-53.

DOI : https://doi.org/10.1016/j.jinf.2016.02.003

Pubmed : 26916042

 

305 - 

A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomised trial

Sophie Abgrall, Antoine Rachas, Jérôme Tourret, Corinne Isnard-Bagnis, Eric Billaud, Pierre Tattevin, Dominique Costagliola, Marguerite Guiguet, Pierre Durieux, Fhdh-Anrs Co4

Clinical Infectious Diseases, 2015, 61 (3), 375-384.

DOI : https://doi.org/10.1093/cid/civ310

Pubmed : 25904366

 

306 - 

Heart transplantation as salvage treatment of intractable infective endocarditis

Marie Aymami, Matthieu Revest, Caroline Piau, Céline Chabanne, François Le Gall, Bernard Lelong, Jean-Philippe Verhoye, Christian Michelet, Pierre Tattevin, Erwan Flécher

Clinical Microbiology and Infection, 2015, 21 (4), 371-e1.

DOI : https://doi.org/10.1016/j.cmi.2014.11.027

Pubmed : 25630459

 

307 - 

Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country

Anne Bourgarit, Gabriel Baron, Guillaume Breton, Pierre Tattevin, Christine Katlama, Clotilde Allavena, Pauline Campa, Philippe Ravaud, Olivier Lortholary, Guislaine Carcelain, Igravih Study Group

Annals of the American Thoracic Society, 2015, 12 (8), 1138-1145.

DOI : https://doi.org/10.1513/AnnalsATS.201412-600OC

Pubmed : 26213798

 

308 - 

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)

Cédric Bretonnière, Marc Leone, Christophe Milési, Bernard Allaouchiche, Laurence Armand-Lefevre, Olivier Baldesi, Lila Bouadma, Dominique Decré, Samy Figueiredo, Rémy Gauzit, Benoit Guery, Nicolas Joram, Boris Jung, Sigismond Lasocki, Alain Lepape et al.

Intensive Care Medicine, 2015, 41 (7), pp.1181-1196.

DOI : https://doi.org/10.1007/s00134-015-3853-7

 

309 - 

Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study

Mathias Bruyand, Fabien Le Marec, Armelle Lavole, Karen Leffondré, Jean Philippe Spano, Vincent Le Moing, Pierre Tattevin, Laura March, Jacques Cadranel, Fabrice Bonnet, Marguerite Guiguet

AIDS. Official journal of the international AIDS Society, 2015, 29 (9), 1105--1109.

DOI : https://doi.org/10.1097/QAD.0000000000000645

Pubmed : 26125142

 

310 - 

Mise au point sur le bon usage des fluoroquinolones administrées par voie systémique chez l’adulte (ciprofloxacine, lévofloxacine, moxifloxacine, norfloxacine, ofloxacine, péfloxacine) [Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin)]

C. Chidiac, J. D. Cavallo, R. Cohen, M. Dupon, T. Galperine, R. Garraffo, B. Garo, R. Gauzit, G. Gavazzi, S. Kouzan, E. Varon, T. Lecompte, O. Leroy, E. Senneville, P. Tattevin et al.

Médecine et Maladies Infectieuses, 2015, 45 (9), 348--373.

DOI : https://doi.org/10.1016/j.medmal.2015.07.003

Pubmed : 26432627